TREATMENT OF MALIGNANT TUMOR WITH APLIDINE Russian patent published in 2005 - IPC

Abstract RU 2261104 C2

FIELD: medicine, oncology.

SUBSTANCE: invention elates to treatment of tumors. Method involves administration of aplidine in the dose not exceeding the recommended dose and limiting by the toxicity of the preparation in patient and in the correspondence of one the following schedule: 24 h infusion, once time per a week for 3 weeks and with the following one resting week; 24 h infusion, once time per two weeks; 1 h infusion, once per a week for 3 weeks in each 4 weeks; 1 h infusion, once per a day for 5 days for 3 weeks; 3 h infusion by each the second week. Applying indicated regimens enhances the effectiveness of treatment of malignant tumors being among them with resistance to the conventional treatment and in combination with the absence of the therapy toxicity.

EFFECT: improved and enhanced effectiveness of treatment.

4 cl, 15 dwg, 18 ex

Similar patents RU2261104C2

Title Year Author Number
COMBINED APPLICATION OF ECTEINASCIDIN-743 AND PLATINUM-CONTAINING ANTI-TUMOUR COMPOUNDS 2004
  • D'Inkal'Chi Mauritsio
  • Dzhanni Luka
  • Dzhavatstsi Rafaehlla
  • Garsija Martin Margarita
  • Dzhadson Jan
  • Khimeno Don'Jake Khose Marija
  • Sessa Krist'Jana
RU2391101C2
IMPROVED SCHEME OF USING ANTITUMOR COMPOUND IN CANCER THERAPY 2002
  • Khimeno Khose
  • Ruis Kasado Ana
  • Lopes Lasaro Luis
  • Rovinski Ehrik
  • Idal'Go Manuehl'
RU2306933C2
COMPOSITION AND UTILIZATION OF ET743 FOR MALIGNANT TUMOR TREATMENT 2000
  • Kvitkovich Ehsteban
  • Demetri Dzhordzh Dehniel
  • Gusman Sesilija
  • Khimeno Khose
  • Lopes Lasaro Luis
  • Misse Zhan Lui
  • Tvelvz K.
  • Fon Khoff Dehniel D.
RU2266734C2
KAHALALIDE F 2001
  • Fehrklot Glinn Tomas
  • Nehjen Bastian
  • Vejtmen Stiv
RU2292216C2
COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID 2011
  • Moneo Okanja Viktorija
  • Santamarija Nunes Khema
  • Garsia Fernandes Luis Fransisko
  • Galmarini Karlos Marija
  • Gilen Navarro Marija Khose
  • Aviles Marin Pablo Manuel
RU2605335C2
APPLICATIONS OF IMMUNOCONJUGATES, THE TARGET OF WHICH IS CD138 2012
  • Shults Gregor
  • Osterrot Frank
  • Kheder Tomas
  • Bryukher Kristof
  • Nimann Gabriele
  • Engling Andre
  • Uerek Kristof
  • Delken Benzhamin
  • Vartenberg-Demand Andrea
  • Tsuber Shantal
  • Gucher Markus
  • Bernester Katrin
  • Kenig Martin
RU2632108C2
APLIDINE FOR TREATMENT OF MYELOMA 2004
  • Bertino Dzhozef R.
  • Medina Dehniel
  • Fehrklot Glinn Tomas
  • Mitsiades Konstantin S.
  • Anderson Kennet
  • Mitsiades Nikolas
RU2335294C2
THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER 2014
  • Sakhin Ugur
  • Tyurechi Ezlem
RU2678700C2
ADVANCED TREATMENT OF TUMOURS 2004
  • Barnedzhi Debabrata
  • Bertino Dzhozef R.
  • Fehrklot Glinn Tomas
  • Gurej Sajdam
  • Khimeno Khose
RU2341283C2
COMBINATION THERAPY WITH ANTITUMOR ALKALOID 2011
  • Moneo Ocana Victoria
  • Santamaria Nunez Gema
  • Garcia Fernandez Luis Francisco
  • Galmarini Carlos Maria
  • Guillen Navarro Maria Jose
  • Aviles Marin Pablo Manuel
RU2743643C2

RU 2 261 104 C2

Authors

Fehjrklot Glinn Tomas

Tvelvz Kris

Pas-Ares Luis

Dates

2005-09-27Published

2000-11-15Filed